AU4688800A - Cyclocarbamate and cyclic amide derivatives - Google Patents

Cyclocarbamate and cyclic amide derivatives

Info

Publication number
AU4688800A
AU4688800A AU46888/00A AU4688800A AU4688800A AU 4688800 A AU4688800 A AU 4688800A AU 46888/00 A AU46888/00 A AU 46888/00A AU 4688800 A AU4688800 A AU 4688800A AU 4688800 A AU4688800 A AU 4688800A
Authority
AU
Australia
Prior art keywords
cyclocarbamate
amide derivatives
cyclic amide
cyclic
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46888/00A
Inventor
James P. Edwards
Andrew Fensome
Todd K. Jones
Arthur A. Santilli
Christopher M Tegley
Andrew Q. Viet
Jay E. Wrobel
Puwen Zhang
Lin Zhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Ligand Pharmaceuticals Inc
Original Assignee
Ligand Pharmaceuticals Inc
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,036 external-priority patent/US6306851B1/en
Application filed by Ligand Pharmaceuticals Inc, American Home Products Corp filed Critical Ligand Pharmaceuticals Inc
Publication of AU4688800A publication Critical patent/AU4688800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
AU46888/00A 1999-05-04 2000-05-01 Cyclocarbamate and cyclic amide derivatives Abandoned AU4688800A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18301599P 1999-05-04 1999-05-04
US60183015 1999-05-04
US09552036 2000-04-19
US09/552,036 US6306851B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate and cyclic amide derivatives
PCT/US2000/011825 WO2000066591A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate and cyclic amide derivatives

Publications (1)

Publication Number Publication Date
AU4688800A true AU4688800A (en) 2000-11-17

Family

ID=26878651

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46888/00A Abandoned AU4688800A (en) 1999-05-04 2000-05-01 Cyclocarbamate and cyclic amide derivatives

Country Status (6)

Country Link
EP (1) EP1185535A1 (en)
JP (1) JP2002543205A (en)
CN (1) CN1349538A (en)
AU (1) AU4688800A (en)
CA (1) CA2371632A1 (en)
MX (1) MXPA01011288A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2585337C (en) * 2004-10-27 2013-12-24 Janssen Pharmaceutica N.V. Trisubstituted thiophenes as progesterone receptor modulators

Also Published As

Publication number Publication date
JP2002543205A (en) 2002-12-17
CA2371632A1 (en) 2000-11-09
EP1185535A1 (en) 2002-03-13
CN1349538A (en) 2002-05-15
MXPA01011288A (en) 2003-07-14

Similar Documents

Publication Publication Date Title
AU4145200A (en) Cyclic compounds and uses thereof
AU2319100A (en) Amide derivatives and drug compositions
AU2001234175A1 (en) Novel cyclic amide derivatives
PL350451A1 (en) Amide derivatives
AU4796700A (en) Ureido-substituted cyclic amine derivatives and their use as drug
IL149374A0 (en) New use and novel n-azabicyclo-amide derivatives
NZ513983A (en) Novel cyclic tetrapeptide derivatives and use thereof as drugs
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU4674900A (en) Cyclic regimens using cyclic urea and cyclic amide derivatives
AU6124999A (en) Hydrazinooxoacetamide derivatives and insecticide
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
EP1194147A4 (en) Arylthiazolidinedione and aryloxazolidinedione derivatives
AU2001243601A1 (en) Caprolactam derivatives and uses thereof
AU6071400A (en) Cyclized amide derivatives
EP1229913A4 (en) Substituted 1-benzazepines and derivatives thereof
AU5979300A (en) Angiopoietin-6 and uses thereof
EP1031954A3 (en) Measuring arrangement and method
AU5974100A (en) 6-carboxyphenyldihydropyridazinone derivatives and use thereof
AU4688800A (en) Cyclocarbamate and cyclic amide derivatives
AU1689600A (en) Amide derivatives
AU2320400A (en) Cyclic amine derivatives and uses thereof
AU2001276716A1 (en) Cyclic amine derivatives and use thereof
AU6075400A (en) N-substituted glycine derivatives
AU6150400A (en) Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase